Posts tagged Securities Act of 1933.
On March 4, 2016, the United States Court of Appeals for the Second Circuit affirmed the District Court for the Southern District of New York in Tongue v. Sanofi, No. 15-588-CV, 2016 WL 851797 (2d Cir. Mar. 4, 2016), holding that the District Court properly dismissed the Investor Plaintiffs/Appellants' Complaint. The Plaintiffs alleged that the Defendants, a pharmaceutical company, its predecessor, and three executives, violated § § 10(b), 18, and 20(a) of the Securities Exchange Act of 1934, § § 11 and 12 of the Securities Act of 1933, and state law by making misleading statements ...
Posted in: Securities Act of 1933
Tags: Biologics License Application, FDA, Genzyme Corporation, Lemtrada, multiple sclerosis Lemtrada, Securities Act of 1933, Securities Exchange Act of 1934, Supplemental Biologics Application, Tongue v. Sanofi
On January 11, 2016, the United States Supreme Court denied the petition for writ of certiorari filed October 29, 2015, by Plaintiff/Appellant NECA-IBEW Pension Trust Fund in its case against Bank of America, its former CEO Ken Lewis, and others in a securities class action. The case originated in the United States District Court for the Southern District of New York. There, NECA-IBEW Pension Trust Fund and Denis Montgomery filed suit alleging violations of § § 11, 12(a)(2), and 15 of the Securities Act of 1933 based on allegations of wrongdoing related to Bank of America's public ...
Posted in: Securities Act of 1933, Supreme Court
Tags: bank of america, burr forman, class action, Ken Lewis, NECA-IBEW Pension Trust Fund v. Lewis, Securities Act of 1933, securities litigation, Securities Litigation & Arbitration, United States Supreme Court
To date, the Stock Market Crash of 1929 was one of the most instrumental events that shaped the securities industry and the laws the govern it. As a result of the crash, Congress enacted the Securities Act of 1933. The '33 Act's goals are to require full disclosure regarding securities offered for public sale, and to prohibit deceit, misrepresentations, and other fraud in the sale of securities. To achieve these goals, securities not subject to an exemption have to be registered so that the investing public can make informed decisions. The next year, Congress enacted the Securities ...
Tags: Dodd-Frank Wall Street Reform and Consumer Protection Act, Sarbanes-Oxley Act of 2002, Securities Act of 1933, securities industry